Innovative Pharmaceutical Biotech (HKSE:00399) Total Stockholders Equity : HK$-601.46 Mil (As of Sep. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Total Stockholders Equity?

Innovative Pharmaceutical Biotech's Total Stockholders Equity for the quarter that ended in Sep. 2023 was HK$-601.46 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Innovative Pharmaceutical Biotech's Book Value per Share for the quarter that ended in Sep. 2023 was HK$-0.41. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Innovative Pharmaceutical Biotech's Debt-to-Equity for the quarter that ended in Sep. 2023 was -1.66.

Innovative Pharmaceutical Biotech Total Stockholders Equity Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Total Stockholders Equity Chart

Innovative Pharmaceutical Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

-74.96

-390.37

-595.35

-549.37

-795.07

Innovative Pharmaceutical Biotech Semi-Annual Data
	Dec13	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															-470.10	-549.37	-665.03	-795.07	-601.46

Innovative Pharmaceutical Biotech (HKSE:00399) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Innovative Pharmaceutical Biotech's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-601.457	-	0)	/	1464.19
	=	-0.41

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Innovative Pharmaceutical Biotech's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(324.628	+	671.179)	/	-601.457
	=	-1.66

Innovative Pharmaceutical Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech (HKSE:00399) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit No. 2111, 21st Floor, Sheung Wan, West Tower Shun Tak Centre, Hong Kong, HKG

Website

http://www.ipb.asia

Innovative Pharmaceutical Biotech Ltd is focused on developing an insulin product that could be administered orally. It has two primary segments of business: the research and development of pharmaceutical products and the trading of beauty products. It generates maximum revenue from trading in the beauty products segment.

Innovative Pharmaceutical Biotech (HKSE:00399) Headlines

No Headlines